HbA1c as indicator for dyslipidaemia, cardiovascular and atherosclerotic events in patients with metabolic syndrome. UTJsci. 2019;5(3):48-56. Accessed May 1, 2024. https://jsci.utq.edu.iq/index.php/main/article/view/138